HIV Prevention 2020: a framework for delivery and a call for action

The Lancet HIV

Volumn 3, Issue 7, 2016, Pages e323-e332

  Dehne, Karl L ^a   Dallabetta, Gina ^b   Wilson, David ^c   Garnett, Geoff P ^b   Laga, Marie ^d   Benomar, Elizabeth ^e   Fakoya, Ade ^f   Baggaley, Rachel C ^g   Nelson, Lisa J ^h   Kasedde, Susan ⁱ   Bermejo, Alvaro ^j   Warren, Mitchell ^k   Benedikt, Clemens ^l  

^a UNAIDS   (Switzerland)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

^c WORLD BANK   (United States)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNITED NATIONS POPULATION FUND   (United States)

^f TUBERCULOSIS AND MALARIA   (Switzerland)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h U S DEPARTMENT OF STATE   (United States)

ⁱ UNITED NATIONS   (United States)

^j International HIV AIDS Alliance   (United Kingdom)

^k AIDS Vaccine Advocacy Coalition   (United States)

^l NONE   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONDOM USE; DRUG ADMINISTRATION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION RELATED TRANSMISSION; MALE TO FEMALE TRANSGENDER; MEN WHO HAVE SEX WITH MEN; MOTHER TO CHILD TRANSMISSION; OPIATE SUBSTITUTION TREATMENT; PRIORITY JOURNAL; PROSTITUTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; DEVELOPING COUNTRY; DISEASE MANAGEMENT; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; INCIDENCE; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; DISEASE MANAGEMENT; FEMALE; GLOBAL HEALTH; HIV INFECTIONS; HUMANS; INCIDENCE;

EID: 84991735034     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(16)30035-2     Document Type: Review

References (86)

1. 1 Auvert, B, Taljaard, D, Lagarde, E, Sobngwi-Tambekou, J, Sitta, R, Puren, A, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med, 2, 2005, e298.
2. 2 Bailey, R, Moses, S, Parker, C, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 (2007), 643–656.
3. 3 Gray, R, Kigozo, G, Serwadda, D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369 (2007), 657–666.
4. 4 Cohen, M, Chen, Y, McCauley, M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365 (2011), 493–505.
5. 5 Thigpen, MC, Kebaabetswe, PM, Paxton, LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 367 (2012), 423–434.
6. 6 Baeten, JM, Donnell, D, Ndase, P, et al. Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women. N Engl J Med 367 (2012), 399–410.
7. 7 Hanenberg, RS, Rojanapithayakorn, W, Kunasol, P, Sokal, DC, Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 344 (1994), 243–245.
8. 8 Kumar, R, Mehendale, SM, Panda, S, et al. Impact of targeted interventions on heterosexual transmission of HIV in India. BMC Public Health, 11, 2011, 549.
9. 9 Pickles, M, Boily, MC, Vickerman, P, et al. Assessment of the population-level effectiveness of the Avahan HIV-prevention programme in South India: a preplanned, causal-pathway-based modelling analysis. Lancet Glob Health 1 (2013), e289–e299.
10. 10 Ramanathan, S, Deshpande, S, Gautam, A, et al. Increase in condom use and decline in prevalence of sexually transmitted infections among high-risk men who have sex with men and transgender persons in Maharashtra, India: Avahan, the India AIDS Initiative. BMC Public Health, 14, 2014, 784.
11. 11 Das, M, Chu, PL, Santos, GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One, 5, 2010, e11068.
12. 12 Grant, RM, Lama, JR, Anderson, PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363 (2010), 2587–2599.
13. 13 Molina JM, Capitant C, Spire B, et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. Conference on Retroviruses and Opportunistic Infections; Seattle, WA; Feb 23–26, 2015. 23B.
14. 14 Ruan, Y, Liang, S, Zhu, J, et al. Evaluation of harm reduction programmes on seroincidence of HIV, hepatitis B and C, syphilis among intravenous drug users in southwest China. Sex Transm Dis 40 (2013), 323–328.
15. 15 Aspinall, E, Dhanya, N, Goldberg, D, Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol 43 (2014), 235–248.
16. 16 MacArthur, GJ, Minozzi, S, Martin, N, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ, 345, 2012, e5945.
17. 17 Stoneburner, RL, Low-Beer, D, Population-level HIV declines and behavioral risk avoidance in Uganda. Science 304 (2004), 714–718.
18. 18 Halperin, DT, Mugurungi, O, Hallett, TB, et al. A surprising prevention success: why did the HIV epidemic decline in Zimbabwe?. PLoS Med, 8, 2011, e1000414.
19. 19 Muchini, B, Benedikt, C, Gregson, S, et al. Local perceptions of the forms, timing and causes of behavior change in response to the AIDS epidemic in Zimbabwe. AIDS Behav 15 (2011), 487–498.
20. 20 Johnson, LF, Hallett, TB, Rehle, TM, Dorrington, RE, The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface 9 (2012), 1544–1554.
21. 21 World Bank, United Nations Population Fund. HIV prevention in generalized epidemics. A review of the evidence, 2013, World Bank, United Nations Population Fund, Washington DC, Johannesburg.
22. 22 UNAIDS 2016 estimates. http://aidsinfo.unaids.org/ (accessed June 10, 2016).
23. 23 ICF International. The Demographic and Health Survey Program. Statcompiler. Rockville. http://beta.statcompiler.com/, 2016 (accessed Aug 6, 2015).
24. 24 WHO. Progress brief. Voluntary medical male circumcision for HIV prevention in 14 priority countries in East and Southern Africa, 2015, World Health Organization, Geneva.
25. 25 Levi J, Raymond A, Pozniak A, et al. Can the UNAIDS 90-90-90 target be achieved? Eighth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015); Vancouver; July 19–22, 2015. MOAD0102.
26. 26 Gaolathe, T, Wirth, KE, Holme, MP, et al. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. Lancet HIV 3 (2016), e221–e230.
27. 27 Pujades Rodríguez, M, Hayes, R, Reducing HIV prevalence among young people: a review of the UNGASS prevalence goal and how it should be monitored. Discussion paper commissioned by WHO. http://www.who.int/hiv/pub/epidemiology/en/reducing_prev_young_people.pdf, October, 2002 (accessed Aug 6, 2015).
28. 28 The International Group on Analysis of Trends in HIV Prevalence and Behaviours in Young People in Countries most Affected by HIV. Trends in HIV prevalence and sexual behaviour among young people aged 15–24 years in countries most affected by HIV. Sex Transm Infect 86:suppl 2 (2010), ii72–ii83.
29. 29 UNAIDS. Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. http://www.unaids.org/sites/default/files/media_asset/20110609_JC2137_Global-Plan-Elimination-HIV-Children_en_1.pdf, 2011 (accessed Aug 6, 2015).
30. 30 UNAIDS. On the fast-track to an AIDS free generation; the incredible journey of the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, 2016, UNAIDS, Geneva http://www.unaids.org/en/resources/documents/2016/GlobalPlan2016 (accessed June 10, 2016).
31. 31 Stover, J, Hallett, TB, Wu, Z, et al. How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV. PLoS One, 9, 2014, e111956.
32. 32 Hoos, D, El-Sadra, W, Dehne, KL, Getting the balance right: Scaling-up treatment and prevention. Glob Public Health, 2016, 10.1080/17441692.2016.1171887 published online April 19.
33. 33 United States Presidents' Emergency Plan on AIDS Relief. DREAMS. Working together for an AIDS-free future for women and girls. http://www.pepfar.gov/documents/organization/252380.pdf (accessed Aug 6, 2015).
34. 34 UNICEF. Synthesis report of the Rapid Assessment of Adolescent and HIV Programme context in five countries: Botswana, Cameroon, Jamaica, Swaziland and Zimbabwe. http://www.childrenandaids.org/publication/synthesis-report-rapid-assessment-adolescent-and-hiv-programme-context-five-countries, December, 2015 (accessed Jan 5, 2016).
35. 35 UN General Assembly. International Covenant on Economic, Social and Cultural Rights. http://www.refworld.org/docid/3ae6b36c0.html, Dec 16, 1966 (accessed Jan 21, 2016).
36. 36 UNAIDS. Fast-track. Ending the AIDS epidemic by 2030. http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf, 2014 (accessed Aug 3, 2015).
37. 37 UNAIDS. Political declaration on HIV and AIDS: on the fast-track to accelerate the fight against HIV and to end the AIDS epidemic by 2030. http://www.unaids.org/en/resources/documents/2016/2016-political-declaration-HIV-AIDS, June 8, 2016 (accessed June 10, 2016).
38. 38 WHO. Prevention and treatment of HIV and other sexually transmitted infections for sex workers in low- and middle-income countries: recommendations for a public health approach. http://www.who.int/hiv/pub/guidelines/sex_worker/en/, December, 2012 (accessed Aug 13, 2015).
39. 39 WHO. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people: recommendations for a public health approach. http://www.who.int/hiv/pub/guidelines/msm_guidelines2011/en/, June, 2011 (accessed Aug 13, 2015).
40. 40 WHO, UNODC. UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users—2012 revision. http://www.who.int/hiv/pub/idu/targets_universal_access/en/, January, 2013 (accessed Aug 13, 2015).
41. 41 Shisana, O, Rehle, T, Simbayi, LC, et al. South African National HIV Prevalence, Incidence and Behaviour Survey 2012, 2014, HSRC Press, Cape Town.
42. 42 Swaziland Ministry of Health and ICAP. Swaziland, HIV Incidence Measurement Survey (SHIMS) First Findings Report. http://files.icap.columbia.edu/shims/files/uploads/SHIMS_First_Findings_Report_w_Cover_2012.pdf, November 2012 (accessed Aug 17, 2015).
43. 43 Lopman, B, Nyamukapa, C, Mushati, P, et al. HIV incidence in 3 years of follow-up of a Zimbabwe cohort—1998–2000 to 2001–03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol 37 (2008), 88–105.
44. 44 Kiwanuka, N, Ssetaala, A, Nalutaaya, A, et al. High incidence of HIV-1 infection in a general population of fishing communities around Lake Victoria, Uganda. PLoS One, 9, 2014, e94932.
45. 45 Anderson, SJ, Cherutich, P, Kilonzo, N, et al. Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study. Lancet 384 (2014), 249–256.
46. 46 UNAIDS. On the Fast-Track to end AIDS by 2030. Focus on location and population. http://www.unaids.org/en/resources/documents/2015/FocusLocationPopulation, 2015 (accessed Aug 4, 2015).
47. 47 Baird, S, Chirwa, E, McIntosh, C, Ozler, B, The short-term impacts of a schooling conditional cash transfer program on the sexual behavior of young women. Health Econ 19:suppl (2010), 55–68.
48. 48 De Neve, JW, Fink, G, Subramanian, SV, Moyo, S, Bor, J, Length of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment. Lancet Glob Health 3 (2015), e470–e477.
49. 49 Abramsky, T, Devries, K, Kiss, L, et al. Findings from the SASA! Study: a cluster randomized controlled trial to assess the impact of a community mobilization intervention to prevent violence against women and reduce HIV risk in Kampala, Uganda. BMC Med, 12, 2014, 122.
50. 50 Jewkes, R, Nduna, M, Levin, J, et al. Impact of Stepping Stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ, 337, 2008, a506.
51. 51 Wagman, JA, Gray, RH, Campbell, JC, et al. Effectiveness of an integrated intimate partner violence and HIV prevention intervention in Rakai, Uganda: analysis of an intervention in an existing cluster randomised cohort. Lancet Glob Health 3 (2015), e23–e33.
52. 52 Hargreaves, JR, Delany-Moretlwe, S, Hallett, TB, et al. The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring. Lancet HIV 3 (2016), e318–e322.
53. 53 UNAIDS. 90-90-90: An ambitious treatment target to end the AIDS epidemic. http://www.unaids.org/en/resources/documents/2014/90-90-90, October, 2014 (accessed Aug 10, 2015).
54. 54 WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565_eng.pdf, September, 2015 (accessed Aug 10, 2015).
55. 55 UNAIDS. On the Fast-Track to end AIDS. UNAIDS Strategy 2016–21. http://www.unaids.org/sites/default/files/media_asset/20151027_UNAIDS_PCB37_15_18_EN_rev1.pdf, 2015 (accessed Nov 4, 2015).
56. 56 Mobula, L, Barnhart, M, Malati, C, et al. Long-acting, injectable antiretroviral therapy for the management of HIV infection: an update on a potential game-changer. J AIDS Clin Res, 6, 2015, 466.
57. 57 Baeten, JM, Palanee-Phillips, T, Brown, ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med, 2016, 10.1056/NEJMoa1506110 published online Feb 22.
58. 58 Shin, SY, Recent update in HIV vaccine development. Clin Exp Vaccine Res 5 (2016), 6–11.
59. 59 Ledikwe, JH, Nyanga, RO, Hagon, J, Grignon, JS, Mpofu, M, Semo, B, Scaling-up voluntary medical male circumcision–what have we learned?. HIV AIDS 6 (2014), 139–146.
60. 60 Shannon, K, Strathdee, S, Goldenberg, S, et al. Global epidemiology of HIV among female sex workers: Influence of structural determinants. Lancet 385 (2015), 55–71.
61. 61 Gruskin, S, Ferguson, L, Alfven, T, Rugg, D, Peersman, G, Identifying structural barriers to an effective HIV response: using the National Composite Policy Index data to evaluate the human rights, legal and policy environment. J Int AIDS Soc, 16, 2013, 18000.
62. 62 Kerrigan, D, Kennedy, CE, Morgan-Thomas, R, et al. A community empowerment approach to the HIV response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up. Lancet 385 (2015), 172–185.
63. 63 Fonner, VA, Armstrong, KS, Kennedy, CE, O'Reilly, KR, Sweat, MD, School based sex education and HIV prevention in low- and middle-income countries: a systematic review and meta-analysis. PLoS One, 9, 2014, e89692.
64. 64 Haberland, NA, The case for addressing gender and power in sexuality and HIV education: a comprehensive review of evaluation studies. Int Perspect Sex Reprod Health 41 (2015), 31–42.
65. 65 Bekker, LG, Venter, F, Cohen, K, et al. Provision of antiretroviral therapy in South Africa: the nuts and bolts. Antivir Ther 19:suppl 3 (2014), 105–116.
66. 66 Mwandi, Z, Murphy, A, Reed, J, et al. Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008–2011. PLoS Med, 8, 2011, e1001130.
67. 67 Verma, R, Shekar, A, Khobragade, S, et al. Scale-up and coverage of Avahan: a large scale HIV-prevention program among female sex workers and men who have sex with men in four Indian states. Sex Transm Infect 86 (2010), i76–i82.
68. 68 Taggart, T, Grewe, ME, Conserve, DF, Gliwa, C, Roman Isler, M, Social media and HIV: a systematic review of uses of social media in HIV communication. Med Internet Res, 17, 2015, e248.
69. 69 United States Center for Disease Control. Real-time data strengthens Uganda's efforts to end mother-to-child HIV transmission. http://www.cdc.gov/globalaids/success-stories/ugandaeoc.html, May 7, 2015 (accessed Aug 6, 2015).
70. 70 Blanchard, JF, Bhattacharjee, P, Kumaran, S, et al. Concepts and strategies for scaling up focused prevention for sex workers in India. Sex Transm Infect 84 (2008), ii19–ii23.
71. 71 Choko, AT, MacPherson, P, Webb, EL, et al. Uptake, accuracy, safety, and linkage into care over two years of promoting annual self-testing for HIV in Blantyre, Malawi: a community-based prospective study. PLoS Med, 12, 2015, e1001873.
72. 72 UNAIDS. Invest in HIV prevention. Quarter for HIV prevention. http://www.unaids.org/sites/default/files/media_asset/JC2791_invest-in-HIV-prevention_en.pdf, 2015 (accessed Feb 22, 2016).
73. 73 Forsythe, S, Stover, J, Bollinger, L, The past, present and future of HIV, AIDS and resource allocation. BMC Public Health, 9(suppl 1), 2009, S4.
74. 74 Kerr, CC, Stuart, RM, Gray, RT, et al. Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization. J Acquir Immune Defic Syndr 69 (2015), 365–376.
75. 75 World Bank, University of New South Wales. Sudan's HIV response: value for money in a low-level HIV epidemic. Findings from the HIV allocative efficiency study. http://www.optimamodel.com/pubs/sudan-report.pdf, September, 2014 (accessed Aug 31, 2015).
76. 76 Kermode, M, Crofts, N, Suresh Kumar, M, Dorabjee, J, Opioid substitution therapy in resource-poor settings. Bull World Health Organ, 89, 2011, 243 243.
77. 77 Republic of Mauritius. Country Progress Report 2015. Global AIDS Response Progress Reporting. Mauritius. http://www.unaids.org/sites/default/files/country/documents/MUS_narrative_report_2015.pdf, 2015 (accessed Aug 17, 2015).
78. 78 Bill & Melinda Gates Foundation. Avahan—the India AIDS Initiative: The business of HIV prevention at scale. https://docs.gatesfoundation.org/Documents/Avahan_HIVPrevention.pdfs (accessed Sept 2, 2015).
79. 79 Wheeler, T, Kiran, U, Dallabetta, G, et al. Learning about scale, measurement and community mobilisation: reflections on the implementation of the Avahan HIV/AIDS Initiative in India. J Epidemiol Community Health 66 (2012), ii16–ii25.
80. 80 Dallabetta, G, Chandrasekaran, P, Wheeler, T, et al. Rolling out new biomedical HIV prevention tools: what can be learned from Avahan, the India AIDS initiative?. Sex Health 11 (2014), 207–216.
81. 81 Pallin, SC, Meekers, D, Lupu, O, Longfield, K, South Africa: a total market approach. http://www.psi.org/wp-content/uploads/2014/10/PSI_SouthAfrica_Dec5finalsmallpdf.com_.pdf, November, 2013 (accessed Sept 4, 2015).
82. 82 Garnett, GP, Hallett, TB, Takaruza, A, et al. Providing a conceptual framework for HIV prevention cascades and assessing feasibility of empirical measurement with data from east Zimbabwe: a case study. Lancet HIV 3 (2016), e297–e306.
83. 83 Sgaier, SK, Baer, J, Rutz, DC, et al. Toward a systematic approach to generating demand for voluntary medical male circumcision: insights and results from field studies. Glob Health Sci Pract 3 (2015), 209–229.
84. 84 WHO. Implementing comprehensive HIV/STI programmes with sex workers: practical approaches from collaborative interventions. http://www.who.int/hiv/pub/sti/sex_worker_implementation/en/, October, 2013 (accessed Aug 17, 2015).
85. 85 World Bank. Ukraine HIV Program Efficiency Study: can Ukraine improve value for money in HIV service delivery?, 2014, World Bank, Washington, DC.
86. 86 Amico, P, Gobet, B, Avila-Figueroa, C, Aran, C, De Lay, P, Pattern and levels of spending allocated to HIV prevention programmes in low- and middle-income countries. BMC Public Health, 12, 2012, 221.